{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "OLPX",
  "name": "Olaplex Holdings, Inc.",
  "url": "https://orbyd.app/dossiers/OLPX/",
  "json_url": "https://orbyd.app/dossiers/OLPX.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Closed by event: the Henkel all-cash takeout completed and OLPX was delisted from Nasdaq on 2026-07-07, with each share converted into the right to receive $2.06 cash. There is no longer a listed security, no price series, and no thesis to trade. The name is a historical entry, not a candidate.",
  "invalidation_trigger": "A daily close below $2.06 can no longer print — Nothing re-opens this name absent a Henkel re-listing of the brand, which is not on any announced calendar.",
  "catalyst_date": "2026-05-05",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "m-and-a-special-situations",
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Will be delisted from Nasdaq on close — no continuing US-listed equity to trade post-deal. Only re-scan as a fresh turnaround candidate if the deal BREAKS and price resets, and only on a clean basing structure, never bottom-fishing the gap.",
    "Peer set is the distressed-consolidation bucket (COTY, EL broken), NOT the e.l.f./momentum beauty cohort — do not pattern-match to the wrong peers.",
    "TERMINAL: merger completed 2026-07-07, shares cancelled at $2.06 cash, delisted and deregistered from Nasdaq Global Select. No tradeable US-listed equity exists.",
    "Deal timeline for the record: announced 2026-03-26 at $2.06/share (~55% premium to the 2026-03-25 close near $1.33); Advent written consent 2026-05-04; Bundeskartellamt cleared 2026-06-16; ACCC cleared ~2026-06-20; remaining US/UK gates satisfied late June; closed pre-open 2026-07-07.",
    "The stale prior read had this as a ~0.5% gross arb spread pending US HSR and UK CMA. Both gates cleared without a second request; the deal-break tail toward the pre-deal ~$1.33 never materialised.",
    "Remove from active watchlist. Any residual scan hits on OLPX are stale-data artifacts, not signal.",
    "Lesson to carry: this was correctly sized at zero the whole way. A cash-pegged equity capped at a fixed takeout price cannot trend, and a 0.5% gross spread over a three-month regulatory tail is a fixed-income return dressed as an equity position.",
    "If the beauty-turnaround theme is wanted again, the live comparables are the distressed prestige bucket (COTY, EL) rather than the ELF momentum cohort. Do not pattern-match Olaplex's takeout outcome onto those names."
  ],
  "body_markdown": "## Current Thesis\nThe story ended on schedule. Henkel completed its all-cash acquisition of Olaplex before the open on **2026-07-07**, and each outstanding share was converted into the right to receive **$2.06 in cash** and cancelled. The shares were delisted from the **Nasdaq Global Select Market** the same day, with deregistration steps initiated. The last print was **$2.07 on 2026-07-06**, a hair through the deal price as arbs closed out. There is no listed OLPX security, no price series, and therefore no setup — the ticker belongs in the historical file rather than any scan.\n\nThe full arc, for the record: announced **2026-03-26** at $2.06 (~55% premium to the 2026-03-25 close near $1.33, ~45% over the 30-day VWAP), shareholder-locked by Advent's written consent on **2026-05-04**, cleared by the Bundeskartellamt on **2026-06-16**, cleared by Australia's ACCC around **2026-06-20**, with the US and UK gates satisfied in the final days of June. No second request, no extension toward the 2027 outside date, no break.\n\n## Bull Case\n- **The deal paid in full**: $2.06 per share in cash delivered at the **2026-07-07** close, against an announced value of ~$1.4B in equity. Holders of record received the full consideration with no downward adjustment.\n- **Regulatory path ran clean**: German clearance came **2026-06-16** on a filing made **2026-05-15** — one month for the buyer's home-market review, the gate most likely to produce friction. Australia followed within a week; the US and UK cleared without a published second request.\n- **Operations gave Henkel no MAC hook**: Q1 2026, reported **2026-05-11**, printed net sales of **$99.4M, +2.5% YoY**, gross margin **72.1%**, Professional **+12.3%** and DTC **+13.8%** — the first positive group comp after a multi-year decline. Balance sheet at 2026-03-31 was **$326.2M cash against $352.5M long-term debt**, near-zero net.\n- **There is no bull case left to underwrite**. The above is settled history; none of it is forward-looking.\n\n## Bear Case\n- **The security no longer exists**: delisted and deregistered as of **2026-07-07**. Any quote, chart, or technical level a data vendor still surfaces for OLPX is a stale artifact.\n- **Zero forward optionality**: the equity was cancelled at a fixed cash price. No trend, no squeeze, no re-rating.\n- **What the takeout actually rescued**: the business had not fixed its problem. Specialty Retail fell **13.3%** and US sales **-3.5%** in Q1 2026; the +2.5% group number leaned entirely on Professional and DTC. Shelf loss to K18, Redken, and L'Oréal-adjacent prestige was never reversed — Henkel bought a distribution asset, not an inflection.\n- **The IPO-to-exit arithmetic is the cautionary line**: public in September 2021 near $21, taken out at $2.06 in under five years.\n\n## Setup & Price Structure\nThere is no chart. The last tape was a flat peg at $2.05–$2.07 into the **2026-07-07** conversion, which is what a cash-locked equity does in its final weeks — arbs collapse the spread and volume dries into the record date. Moving averages, RSI, breakout retests and volume expansion are all inapplicable to a security trading against a fixed cash ceiling, and doubly so to one that no longer trades at all.\n\nFor anyone modelling the terminal spread: at $2.05 against $2.06 with a July close, the gross was roughly **0.5%** over a three-month regulatory tail. That is a fixed-income return with equity-style headline risk, and it was never the kind of asymmetry a momentum book exists to capture.\n\n## Catalyst Calendar (next 30 days)\n\n- No future earnings, guidance, regulatory, or corporate-action dates are scheduled for this ticker, now or later.\n\n## Elapsed catalysts\n\n- **None.** All dated events are behind: merger close **2026-07-07**, delisting **2026-07-07**, deregistration filings following. *(passed 33d ago)*\n- **2026-06-16** — Bundeskartellamt clearance (elapsed). *(passed 54d ago)*\n- **~2026-06-20** — ACCC clearance (elapsed). *(passed 50d ago)*\n- **2026-05-11** — final earnings report; guidance withdrawn and the conference call cancelled into the pending transaction. No further reporting obligation exists. *(passed 90d ago)*\n\n## What Would Change Our Mind\nNothing available in the market. The only theoretical path back to a listed Olaplex equity is Henkel re-floating or spinning the brand, which appears on no announced calendar and would take years. Absent that, the name is permanently retired from the watchlist.\n\nThe one live read that survives is negative and applies elsewhere: the Olaplex outcome is not a template for the rest of the distressed prestige-beauty complex. A $2.06 cash exit at ~90% below the 2021 IPO price is a rescue, not a valuation floor for peers.\n\n## Correlation Notes\n- **M&A special situations**: while pending, OLPX correlated to nothing but its own deal spread — beta to the tape was effectively zero from **2026-03-26** through delisting. That is the defining property of the cash-pegged bucket and the reason it does not belong in a trend book.\n- **Beauty peers (COTY, EL, ULTA, ELF)**: correlation broke on the **2026-03-26** announcement and never re-established. Post-close there is no residual read-across; Olaplex's takeout removed a share-donor from the category rather than repricing it.\n- **Henkel (HEN3.DE)**: the acquirer now carries the asset. Any forward interest in the Olaplex brand's trajectory routes through a German-listed consumer-goods name with a very different volatility profile.\n- **Stale-data risk**: legacy theme tags on this ticker — earlier registry passes attached \"specialty-healthcare-late-cycle\" and \"semi-foundry-equipment\" — were misclassifications that persisted across regens. Worth flagging as a general reminder that theme drift on a dormant ticker compounds unnoticed.",
  "first_seen": "2026-04-20",
  "last_analyzed": "2026-07-19T11:01:10+00:00",
  "last_synthesized": "2026-07-19",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}